Because TARC and MDC are well-known Th2 chemokines, highly expressed in skin lesions and plasma of patients with AD [9,10,54], the inhibitory activity of SFII against TNF-α/IFN-γ-induced TARC and MDC expression suggests its possible anti-inflammatory effects on AD. Here, TNF is linked to Alzheimer disease.